Medical Infusion Mixing Device Research: expanding at a CAGR of 11.2% during the forecast period (2025–2031)
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report “Medical Infusion Mixing Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031”. Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Medical Infusion Mixing Device was estimated to be worth US$ 1865 million in 2024 and is forecast to a readjusted size of US$ 3921 million by 2031 with a CAGR of 11.2% during the forecast period 2025-2031.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4842974/medical-infusion-mixing-device
Global Medical Infusion Mixing Device Market to Reach USD 3.92 Billion by 2031 at 11.2% CAGR, Led by Baxter and Fresenius Kabi
The global medical infusion mixing device market, valued at USD 1,865 million in 2024, is projected to reach USD 3,921 million by 2031, expanding at a CAGR of 11.2% during the forecast period (2025–2031). According to the latest 2025 market research, this rapid growth is fueled by increasing demand for automated and precise drug administration, driven by advancements in infusion technology, the rise of home healthcare, and integration of digital monitoring systems.
In 2024, global production of medical infusion mixing devices reached approximately 621 thousand units, with an average market price of USD 3,000 per unit. Medical infusion mixing devices are designed to automatically and safely mix multiple drug solutions during infusion therapy, ensuring accuracy and efficiency in hospital and critical care settings.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample/4842976
Key Players and Competitive Landscape
Leading global manufacturers include:
· Baxter International
· B. Braun Melsungen
· Fresenius Kabi
· Becton Dickinson
· Smiths Medical
· ICU Medical
· Terumo Corporation
· Nipro Corporation
· Hospira
· Medtronic
· Mindray
· Weigao Group
· Codan Medical
· Grifols
· Vygon Group
· Omnicell
· Micrel Medical
· West Pharmaceutical Services
ICU Medical – Plum Solo™ Precision IV Pump
· Company: ICU Medical
· Product: Plum Solo™ singlechannel precision IV pump
· FDA Clearance: April 7, 2025 (510(k) K242114)
· Accuracy: ±3 % under realworld conditions using patented cassette technology
· Display: 7-inch fullcolor touchscreen with safety feedback
· Supports: whole blood, blood products, variable temperature and elevation conditions
Baxter – NOVUM IQ Syringe Infusion System
· Company: Baxter International
· Product: NOVUM IQ syringe infusion pump
· Flow rate precision:
o 0.01–99.99 mL/hr (±0.01 mL/hr)
o 100–999.9 mL/hr (±0.1 mL/hr)
o 1,000–1,200 mL/hr (±1 mL/hr)
· Syringe capacity: 1–60 mL, maximum volume 999 mL; KVO configured to keep infusion until empty
· Dose modes: supports mg/kg, mL/kg, dose/time, bolus/loading, rate changes, body weight/BSA inputs
Fresenius Kabi – Ivenix Infusion System
· Company: Fresenius Kabi
· Product: Ivenix™ Infusion System (volumetric/pneumatic pump)
· EMR Integration: full connectivity with electronic medical records
· Pumping tech: advanced pneumatic flow control for precise medication delivery and safety
· Safety features: prevention of medication errors, airembolism, overinfusion alerts
B. Braun – PINNACLE® SingleChamber Mixing Container (EVA, 1000 mL)
· Company: B. Braun Melsungen
· Product: PINNACLE® EVA singlechamber 3in1 mixing container (1,000 mL)
· Purpose: gravitybased total parenteral nutrition (TPN) mixing and transfer, closed system
· Advantages: streamlines safe TPN delivery, reduces contamination risk, simplified compounding
Medtronic – Extended™ Infusion Set (Insulin Delivery)
· Company: Medtronic
· Product: Extended™ infusion set and reservoir for insulin pumps
· Wear duration: up to 7 days per set vs typical 2–3 days (one change per week)
· Target users: individuals with dexterity issues, needle anxiety, active lifestyles
· Features: soft cannula, hypoallergenic adhesive, low profile, widely used with MiniMed systems
· Automatic Infusion Mixing Devices
· Manual Infusion Mixing Devices
· Hospital Clinical Departments
· Intensive Care Units
· Operating Rooms
· Emergency & Transport
· Others
North America, Europe, and Asia-Pacific remain the dominant markets. Asia-Pacific is expected to demonstrate the fastest growth rate due to rising hospital construction, expanding healthcare infrastructure, and increased adoption of automated infusion solutions. Meanwhile, U.S. tariff adjustments in 2025 have introduced supply chain uncertainties, prompting manufacturers to explore diversified sourcing and regional assembly strategies.
In 2025, the infusion mixing device market is experiencing a strong pivot toward fully automated systems integrated within hospital IT infrastructures. Smart pumps equipped with drug libraries, doseerror reduction software, and wireless communication capabilities not only minimize human error, but also streamline workflows across clinical teams. Hospitals increasingly require infusion pumps that communicate bidirectionally with EMR/EHR systems via WiFi or Bluetooth, enabling remote monitoring, fleet oversight, and realtime alerts.
Remote patient monitoring (RPM) technologies are now widely deployed, enabling infusion devices to transmit usage data, vital signs, and device status directly to centralized monitoring platforms. This capability supports telehealth workflows and improves patient safety outside acute care settings. The broader infusion pump market—which reached approximately USD 11.3 billion in 2025—is growing rapidly, driven by homebased care and ambulatory infusion programs with connected device support.
Emerging pressureenabled drug delivery technologies are gaining traction, especially for highviscosity biologics and targeted therapies requiring controlled pressure and flow profiles. These systems improve absorption efficiency and dosing consistency through carefully engineered actuation mechanisms. Developers are customizing mechanical components—such as motors, gears, and actuators—to deliver consistent flow control for both IV and subcutaneous applications in wearable formats.
With increased demand in emergency medicine, transport, and home infusion, manufacturers are reducing device size and weight without compromising accuracy or safety. Miniaturized volumetric and syringe pumps now offer precision delivery in outpatient environments like ASCs and ambulatory infusion centers. Elastomeric infusion pumps—with capacity for continuous or variable-rate dispensing—are also being updated with improved interfaces and sustainability enhancements.
Integration trends are reshaping procurement decisions: hospitals now evaluate infusion devices based on interoperability with EMR systems, fleet management dashboards, and remote safety analytics. The advanced infusion systems segment (including volumetric and multitherapy pumps) is forecast to climb from USD 10.3 billion in 2025 to nearly USD 19.1 billion by 2035, with volumetric systems leading at 38 % market share. Regional leadership remains with North America, driven by regulatory incentives and high chronic illness prevalence, but AsiaPacific is the fastestgrowing region due to expanding healthcare infrastructure and home infusion adoption.
Request for Pre-Order Enquiry On This Report https://www.qyresearch.com/customize/4842976
· Saint Francis Medical Center
· Mayo Clinic
· UCL Hospitals
· Cleveland Clinic
· Johns Hopkins Hospital
· Massachusetts General Hospital
· Mount Sinai Health System
· Houston Methodist Hospital
· Stanford Health Care
· Toronto General Hospital
· Charité – Universitätsmedizin Berlin
· Singapore General Hospital
· Siriraj Hospital
· Royal Prince Alfred Hospital
· Hospital Israelita Albert Einstein
With an anticipated 11.2% CAGR through 2031, the medical infusion mixing device market is positioned for robust expansion. Companies that prioritize automation, connectivity, and supply chain resilience will lead in both hospital and home infusion markets. Growing adoption of portable, accurate, and EMR-integrated solutions indicates that precision and digital transformation will remain at the forefront of market competition.
The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.
The Medical Infusion Mixing Device market is segmented as below:
By Company
Baxter International
B. Braun Melsungen
Fresenius Kabi
Becton Dickinson
Smiths Medical
ICU Medical
Terumo Corporation
Nipro Corporation
Hospira
Medtronic
Mindray
Weigao Group
JMS Co.
Codan Medical
Grifols
Ostec Medical
Kawasumi Laboratories
Renolit
Zyno Medical
Vygon Group
Woo Young Medical
Biosensors International
Bicakcilar
Polymedicure
Wego Medical
Biosafe SA
Pentaferte Group
Omnicell
Micrel Medical
West Pharmaceutical Services
Segment by Type
Automatic Infusion Mixing Device
Manual Infusion Mixing Device
Segment by Application
Hospital Clinical Departments
Intensive Care Units
Operating Rooms
Emergency & Transport
Others
Each chapter of the report provides detailed information for readers to further understand the Medical Infusion Mixing Device market:
Chapter 1: Introduces the report scope of the Medical Infusion Mixing Device report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2020-2031)
Chapter 2: Detailed analysis of Medical Infusion Mixing Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2020-2025)
Chapter 3: Provides the analysis of various Medical Infusion Mixing Device market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2020-2031)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2020-2031)
Chapter 5: Sales, revenue of Medical Infusion Mixing Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2020-2031)
Chapter 6: Sales, revenue of Medical Infusion Mixing Device in country level. It provides sigmate data by Type, and by Application for each country/region.(2020-2031)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2020-2025)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Benefits of purchasing QYResearch report:
Competitive Analysis: QYResearch provides in-depth Medical Infusion Mixing Device competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.
Industry Analysis: QYResearch provides Medical Infusion Mixing Device comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.
and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.
Market Size: QYResearch provides Medical Infusion Mixing Device market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.
Other relevant reports of QYResearch:
Global Medical Infusion Mixing Device Market Research Report 2025
Global Medical Infusion Mixing Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Medical Infusion Mixing Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 18 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.